Esegui ricerca
The Netherlands, Genetics
New therapy against rare gene defects
New therapy against rare gene defects
European scientists set up new therapeutic approaches to tackle specific Lysosomal Storage Disorders: a new drug combination and enzyme replacement therapy against Pompe disease and gene therapy against MPS V I (Mucopolysaccharidosis VI).
How many pills? Ask your genes
How many pills? Ask your genes
European researchers have looked how the analysis of your genes could help to determine the dosage for patients who need to take blood thinners.
Anke-Hilse Maitland van der Zee - Blood thinners at the right dose
Anke-Hilse Maitland van der Zee - Blood thinners at the right dose
Coumarins— blood thinners against thrombosis, or blood clotting, are amongst the most widely used drugs worldwide. Millions of mostly elderly people depend on them. But finding the right dosage is a painstaking process.
Better diagnostics for thrombosis are a matter of resources
Better diagnostics for thrombosis are a matter of resources
Cost-effectiveness is paramount for any new medical technology. If pharmaceutical companies do not see a profit, new drugs will never see the light of day.
The case for low methane-emitting cattle
The case for low methane-emitting cattle
You may think that climate change is being caused by burning oil, coal and gas. But not so fast! The emission of methane from cattle is a surprisingly important factor .
Anti-allergy GM apples
Anti-allergy GM apples
Peanut, egg and soy are more common food known to trigger an allergic reaction, a problem affecting around 8% of children in the EU. Intuitively, you might not list apples as causing allergic reactions.